 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || HK-001 / Everfront Biotech
Trial completion date, Trial primary completion date: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - Sep 7, 2023
P1, N=56, Active, not recruiting, Sponsor: Everfront Biotech Co., Ltd.
Trial completion date: Dec 2023 --> Jun 2025 | Trial primary completion date: Jun 2023 --> Dec 2024
- || HK-001 / Everfront Biotech
Trial primary completion date: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - Jan 18, 2023
P1, N=56, Active, not recruiting, Sponsor: Everfront Biotech Co., Ltd.
Trial completion date: Dec 2023 --> Jun 2025 | Trial primary completion date: Jun 2023 --> Dec 2024 Trial primary completion date: Dec 2022 --> Jun 2023
- || HK-001 / Everfront Biotech
Enrollment closed: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - Jul 27, 2022
P1, N=56, Active, not recruiting, Sponsor: Everfront Biotech Co., Ltd.
Trial primary completion date: Dec 2022 --> Jun 2023 Recruiting --> Active, not recruiting
- ||| HK-001 / Everfront Biotech
Enrollment open: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - Jan 8, 2021
P1, N=56, Recruiting, Sponsor: Everfront Biotech Co., Ltd.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || HK-001 / Everfront Biotech
Trial completion date, Trial primary completion date: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - Apr 12, 2020
P1, N=56, Not yet recruiting, Sponsor: Everfront Biotech Co., Ltd.
Not yet recruiting --> Recruiting Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2021 --> Dec 2022
- || HK-001 / Everfront Biotech
Trial completion date, Trial initiation date, Trial primary completion date: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - May 10, 2019
P1, N=56, Not yet recruiting, Sponsor: Everfront Biotech Co., Ltd.
Trial completion date: Dec 2022 --> Dec 2023 | Trial primary completion date: Dec 2021 --> Dec 2022 Trial completion date: Dec 2020 --> Dec 2022 | Initiation date: Feb 2019 --> Jan 2020 | Trial primary completion date: Dec 2020 --> Dec 2021
- || HK-001 / Everfront Biotech
Trial initiation date: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - Dec 27, 2018
P1, N=56, Not yet recruiting, Sponsor: Everfront Biotech Co., Ltd.
Trial completion date: Dec 2020 --> Dec 2022 | Initiation date: Feb 2019 --> Jan 2020 | Trial primary completion date: Dec 2020 --> Dec 2021 Initiation date: Sep 2018 --> Feb 2019
- | HK-001 / Everfront Biotech
New P1 trial: To Determine the Maximum Tolerated Dose (MTD) of HK-001 in Healthy Volunteers (clinicaltrials.gov) - Aug 29, 2018
P1, N=56, Not yet recruiting, Sponsor: Everfront Biotech Co., Ltd.